nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—DRD4—conduct disorder	0.55	0.685	CbGaD
Olanzapine—HTR2A—conduct disorder	0.253	0.316	CbGaD
Olanzapine—ORM1—saliva—conduct disorder	0.00665	0.17	CbGeAlD
Olanzapine—HTR7—autonomic nervous system—conduct disorder	0.00492	0.126	CbGeAlD
Olanzapine—HTR2A—autonomic nervous system—conduct disorder	0.00307	0.0785	CbGeAlD
Olanzapine—HTR5A—brain—conduct disorder	0.00306	0.0781	CbGeAlD
Olanzapine—DRD4—brain—conduct disorder	0.00151	0.0387	CbGeAlD
Olanzapine—HTR1E—brain—conduct disorder	0.0013	0.0334	CbGeAlD
Olanzapine—CHRM4—brain—conduct disorder	0.00114	0.0293	CbGeAlD
Olanzapine—Amoxapine—DRD4—conduct disorder	0.00112	0.174	CrCbGaD
Olanzapine—DRD3—brain—conduct disorder	0.00106	0.0272	CbGeAlD
Olanzapine—FMO3—brain—conduct disorder	0.00105	0.0269	CbGeAlD
Olanzapine—HTR6—brain—conduct disorder	0.00102	0.0262	CbGeAlD
Olanzapine—DRD5—brain—conduct disorder	0.000997	0.0255	CbGeAlD
Olanzapine—HRH2—brain—conduct disorder	0.000936	0.0239	CbGeAlD
Olanzapine—CHRM5—brain—conduct disorder	0.000894	0.0229	CbGeAlD
Olanzapine—Loxapine—DRD4—conduct disorder	0.000874	0.136	CrCbGaD
Olanzapine—Quetiapine—DRD4—conduct disorder	0.000853	0.133	CrCbGaD
Olanzapine—ADRA1B—brain—conduct disorder	0.000817	0.0209	CbGeAlD
Olanzapine—H1F0—brain—conduct disorder	0.000771	0.0197	CbGeAlD
Olanzapine—DRD1—brain—conduct disorder	0.000762	0.0195	CbGeAlD
Olanzapine—HTR3A—brain—conduct disorder	0.000736	0.0188	CbGeAlD
Olanzapine—Clozapine—DRD4—conduct disorder	0.000734	0.114	CrCbGaD
Olanzapine—Amoxapine—SLC6A4—conduct disorder	0.000671	0.104	CrCbGaD
Olanzapine—HTR1B—brain—conduct disorder	0.000617	0.0158	CbGeAlD
Olanzapine—CHRM2—brain—conduct disorder	0.000614	0.0157	CbGeAlD
Olanzapine—HTR1D—brain—conduct disorder	0.000597	0.0153	CbGeAlD
Olanzapine—HTR2C—brain—conduct disorder	0.000592	0.0151	CbGeAlD
Olanzapine—ALB—brain—conduct disorder	0.000577	0.0148	CbGeAlD
Olanzapine—CHRM1—brain—conduct disorder	0.000559	0.0143	CbGeAlD
Olanzapine—HTR2B—brain—conduct disorder	0.000556	0.0142	CbGeAlD
Olanzapine—Loxapine—SLC6A4—conduct disorder	0.000524	0.0816	CrCbGaD
Olanzapine—Amoxapine—HTR2A—conduct disorder	0.000516	0.0803	CrCbGaD
Olanzapine—CHRM3—brain—conduct disorder	0.0005	0.0128	CbGeAlD
Olanzapine—HTR1A—brain—conduct disorder	0.000498	0.0127	CbGeAlD
Olanzapine—HTR7—brain—conduct disorder	0.000476	0.0122	CbGeAlD
Olanzapine—ADRA1A—brain—conduct disorder	0.000459	0.0117	CbGeAlD
Olanzapine—DRD2—brain—conduct disorder	0.00045	0.0115	CbGeAlD
Olanzapine—ADRA2C—brain—conduct disorder	0.000437	0.0112	CbGeAlD
Olanzapine—Loxapine—HTR2A—conduct disorder	0.000403	0.0627	CrCbGaD
Olanzapine—Quetiapine—HTR2A—conduct disorder	0.000393	0.0612	CrCbGaD
Olanzapine—HRH1—brain—conduct disorder	0.000355	0.00909	CbGeAlD
Olanzapine—ADRA2A—brain—conduct disorder	0.000349	0.00892	CbGeAlD
Olanzapine—Clozapine—HTR2A—conduct disorder	0.000338	0.0526	CrCbGaD
Olanzapine—HTR2A—brain—conduct disorder	0.000297	0.00759	CbGeAlD
Olanzapine—CYP2D6—brain—conduct disorder	0.00027	0.00691	CbGeAlD
Olanzapine—ABCB1—brain—conduct disorder	0.000194	0.00497	CbGeAlD
Olanzapine—HTR1E—Signaling Pathways—DRD4—conduct disorder	4.28e-05	0.000282	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—DRD4—conduct disorder	4.26e-05	0.000281	CbGpPWpGaD
Olanzapine—HRH2—Signaling by GPCR—HTR2A—conduct disorder	4.21e-05	0.000278	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—DRD4—conduct disorder	4.2e-05	0.000277	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—WASF1—conduct disorder	4.19e-05	0.000276	CbGpPWpGaD
Olanzapine—DRD5—Signaling by GPCR—HTR2A—conduct disorder	4.18e-05	0.000276	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—WASF1—conduct disorder	4.18e-05	0.000276	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	4.18e-05	0.000276	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—WASF1—conduct disorder	4.15e-05	0.000274	CbGpPWpGaD
Olanzapine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	4.09e-05	0.00027	CbGpPWpGaD
Olanzapine—CYP3A4—Biological oxidations—COMT—conduct disorder	4.09e-05	0.000269	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—WASF1—conduct disorder	4.07e-05	0.000268	CbGpPWpGaD
Olanzapine—CYP3A4—Biological oxidations—MAOA—conduct disorder	4.06e-05	0.000268	CbGpPWpGaD
Olanzapine—DRD2—Circadian rythm related genes—EP300—conduct disorder	4.06e-05	0.000267	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	4.04e-05	0.000266	CbGpPWpGaD
Olanzapine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	4.03e-05	0.000266	CbGpPWpGaD
Olanzapine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	4.02e-05	0.000265	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	4.01e-05	0.000265	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CGA—conduct disorder	4e-05	0.000264	CbGpPWpGaD
Olanzapine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	4e-05	0.000264	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—WASF1—conduct disorder	4e-05	0.000264	CbGpPWpGaD
Olanzapine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	3.99e-05	0.000263	CbGpPWpGaD
Olanzapine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	3.97e-05	0.000262	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—CGA—conduct disorder	3.96e-05	0.000261	CbGpPWpGaD
Olanzapine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	3.95e-05	0.000261	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—WASF1—conduct disorder	3.95e-05	0.00026	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	3.94e-05	0.00026	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	3.9e-05	0.000258	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CGA—conduct disorder	3.87e-05	0.000255	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CGA—conduct disorder	3.85e-05	0.000254	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	3.84e-05	0.000253	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—WASF1—conduct disorder	3.82e-05	0.000252	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—DRD4—conduct disorder	3.81e-05	0.000251	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	3.8e-05	0.00025	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—DRD4—conduct disorder	3.79e-05	0.00025	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—WASF1—conduct disorder	3.78e-05	0.000249	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CGA—conduct disorder	3.74e-05	0.000247	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CGA—conduct disorder	3.68e-05	0.000243	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	3.66e-05	0.000242	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	3.66e-05	0.000241	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	3.65e-05	0.00024	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—CGA—conduct disorder	3.63e-05	0.00024	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—WASF1—conduct disorder	3.6e-05	0.000238	CbGpPWpGaD
Olanzapine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	3.56e-05	0.000235	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—WASF1—conduct disorder	3.55e-05	0.000234	CbGpPWpGaD
Olanzapine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	3.55e-05	0.000234	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	3.55e-05	0.000234	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	3.54e-05	0.000234	CbGpPWpGaD
Olanzapine—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	3.53e-05	0.000233	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	3.49e-05	0.00023	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	3.49e-05	0.00023	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	3.48e-05	0.000229	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	3.47e-05	0.000229	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	3.46e-05	0.000228	CbGpPWpGaD
Olanzapine—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	3.46e-05	0.000228	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	3.42e-05	0.000226	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	3.41e-05	0.000225	CbGpPWpGaD
Olanzapine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	3.4e-05	0.000224	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CGA—conduct disorder	3.39e-05	0.000224	CbGpPWpGaD
Olanzapine—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	3.36e-05	0.000221	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CGA—conduct disorder	3.34e-05	0.00022	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CGA—conduct disorder	3.33e-05	0.00022	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CGA—conduct disorder	3.32e-05	0.000219	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CGA—conduct disorder	3.31e-05	0.000218	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CGA—conduct disorder	3.28e-05	0.000216	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CGA—conduct disorder	3.27e-05	0.000216	CbGpPWpGaD
Olanzapine—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	3.25e-05	0.000214	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	3.23e-05	0.000213	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	3.23e-05	0.000213	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—DRD4—conduct disorder	3.22e-05	0.000212	CbGpPWpGaD
Olanzapine—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	3.21e-05	0.000212	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	3.21e-05	0.000212	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—HTR2A—conduct disorder	3.21e-05	0.000212	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	3.21e-05	0.000211	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	3.17e-05	0.000209	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	3.17e-05	0.000209	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—DRD4—conduct disorder	3.16e-05	0.000208	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	3.15e-05	0.000208	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	3.14e-05	0.000207	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	3.14e-05	0.000207	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	3.11e-05	0.000205	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	3.1e-05	0.000204	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—WASF1—conduct disorder	3.1e-05	0.000204	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	3.09e-05	0.000204	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—WASF1—conduct disorder	3.08e-05	0.000203	CbGpPWpGaD
Olanzapine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	3.06e-05	0.000202	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	3.05e-05	0.000201	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CGA—conduct disorder	3.04e-05	0.0002	CbGpPWpGaD
Olanzapine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	3.02e-05	0.000199	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	3e-05	0.000198	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	2.95e-05	0.000195	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	2.95e-05	0.000194	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—DRD4—conduct disorder	2.92e-05	0.000193	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—DRD4—conduct disorder	2.92e-05	0.000193	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	2.92e-05	0.000192	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—DRD4—conduct disorder	2.9e-05	0.000191	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	2.88e-05	0.00019	CbGpPWpGaD
Olanzapine—ALB—Metabolism—CGA—conduct disorder	2.87e-05	0.000189	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—DRD4—conduct disorder	2.84e-05	0.000187	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—HTR2A—conduct disorder	2.79e-05	0.000184	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	2.78e-05	0.000183	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—DRD4—conduct disorder	2.76e-05	0.000182	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	2.74e-05	0.000181	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—EP300—conduct disorder	2.74e-05	0.000181	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	2.73e-05	0.00018	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—WASF1—conduct disorder	2.72e-05	0.000179	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—WASF1—conduct disorder	2.68e-05	0.000176	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—WASF1—conduct disorder	2.67e-05	0.000176	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—DRD4—conduct disorder	2.67e-05	0.000176	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—WASF1—conduct disorder	2.66e-05	0.000176	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—WASF1—conduct disorder	2.65e-05	0.000175	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—DRD4—conduct disorder	2.64e-05	0.000174	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	2.63e-05	0.000174	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—WASF1—conduct disorder	2.63e-05	0.000173	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	2.62e-05	0.000173	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	2.62e-05	0.000173	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	2.62e-05	0.000172	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—CGA—conduct disorder	2.57e-05	0.00017	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	2.55e-05	0.000168	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—DRD4—conduct disorder	2.52e-05	0.000166	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CGA—conduct disorder	2.51e-05	0.000166	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	2.51e-05	0.000165	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—HTR2A—conduct disorder	2.49e-05	0.000164	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—DRD4—conduct disorder	2.48e-05	0.000164	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	2.48e-05	0.000163	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—HTR2A—conduct disorder	2.47e-05	0.000163	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	2.43e-05	0.000161	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	2.39e-05	0.000158	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	2.38e-05	0.000157	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CGA—conduct disorder	2.37e-05	0.000156	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CGA—conduct disorder	2.35e-05	0.000155	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	2.31e-05	0.000153	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	2.31e-05	0.000152	CbGpPWpGaD
Olanzapine—ADRA2B—Hemostasis—EP300—conduct disorder	2.29e-05	0.000151	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	2.28e-05	0.00015	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	2.27e-05	0.00015	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	2.26e-05	0.000149	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	2.26e-05	0.000149	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	2.24e-05	0.000148	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	2.23e-05	0.000147	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.23e-05	0.000147	CbGpPWpGaD
Olanzapine—FMO3—Metabolism—EP300—conduct disorder	2.2e-05	0.000145	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.16e-05	0.000143	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.15e-05	0.000142	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—EP300—conduct disorder	2.14e-05	0.000141	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.1e-05	0.000138	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.09e-05	0.000138	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.07e-05	0.000136	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.06e-05	0.000136	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.06e-05	0.000136	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	2.05e-05	0.000135	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	2.05e-05	0.000135	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	2.03e-05	0.000134	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.02e-05	0.000133	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—COMT—conduct disorder	2.02e-05	0.000133	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CGA—conduct disorder	2.01e-05	0.000132	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—MAOA—conduct disorder	2.01e-05	0.000132	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—HTR2A—conduct disorder	1.91e-05	0.000126	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—HTR2A—conduct disorder	1.91e-05	0.000126	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—DRD4—conduct disorder	1.9e-05	0.000125	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—HTR2A—conduct disorder	1.89e-05	0.000125	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	1.88e-05	0.000124	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—DRD4—conduct disorder	1.87e-05	0.000123	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—DRD4—conduct disorder	1.87e-05	0.000123	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—DRD4—conduct disorder	1.86e-05	0.000123	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—DRD4—conduct disorder	1.85e-05	0.000122	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—HTR2A—conduct disorder	1.85e-05	0.000122	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—DRD4—conduct disorder	1.84e-05	0.000121	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	1.83e-05	0.000121	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—HTR2A—conduct disorder	1.82e-05	0.00012	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—HTR2A—conduct disorder	1.8e-05	0.000119	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—COMT—conduct disorder	1.79e-05	0.000118	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—MAOA—conduct disorder	1.77e-05	0.000117	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—HTR2A—conduct disorder	1.74e-05	0.000115	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—EP300—conduct disorder	1.73e-05	0.000114	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—HTR2A—conduct disorder	1.72e-05	0.000114	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	1.7e-05	0.000112	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—EP300—conduct disorder	1.7e-05	0.000112	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—HTR2A—conduct disorder	1.64e-05	0.000108	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—COMT—conduct disorder	1.64e-05	0.000108	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—MAOA—conduct disorder	1.63e-05	0.000107	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—HTR2A—conduct disorder	1.62e-05	0.000107	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CGA—conduct disorder	1.55e-05	0.000102	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—EP300—conduct disorder	1.48e-05	9.76e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	1.46e-05	9.65e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.41e-05	9.31e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.41e-05	9.27e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—EP300—conduct disorder	1.37e-05	9.03e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.37e-05	9.01e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.35e-05	8.87e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—EP300—conduct disorder	1.32e-05	8.69e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—EP300—conduct disorder	1.31e-05	8.64e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—COMT—conduct disorder	1.29e-05	8.54e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—MAOA—conduct disorder	1.29e-05	8.48e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.25e-05	8.22e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.24e-05	8.18e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.22e-05	8.03e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.21e-05	8e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.21e-05	7.98e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.2e-05	7.9e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.19e-05	7.88e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—COMT—conduct disorder	1.16e-05	7.66e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—MAOA—conduct disorder	1.15e-05	7.61e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—COMT—conduct disorder	1.13e-05	7.48e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—MAOA—conduct disorder	1.13e-05	7.43e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.12e-05	7.38e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.11e-05	7.32e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—COMT—conduct disorder	1.07e-05	7.05e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—MAOA—conduct disorder	1.06e-05	7e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—COMT—conduct disorder	1.06e-05	6.99e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—MAOA—conduct disorder	1.05e-05	6.94e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.02e-05	6.73e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—EP300—conduct disorder	1.01e-05	6.67e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—EP300—conduct disorder	1.01e-05	6.66e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—EP300—conduct disorder	1e-05	6.62e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—EP300—conduct disorder	9.82e-06	6.48e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—EP300—conduct disorder	9.67e-06	6.37e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—EP300—conduct disorder	9.54e-06	6.29e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—EP300—conduct disorder	9.23e-06	6.09e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—EP300—conduct disorder	9.13e-06	6.02e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—COMT—conduct disorder	9.05e-06	5.97e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—MAOA—conduct disorder	8.99e-06	5.93e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	8.72e-06	5.75e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—EP300—conduct disorder	8.7e-06	5.74e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—EP300—conduct disorder	8.66e-06	5.71e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EP300—conduct disorder	8.59e-06	5.66e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EP300—conduct disorder	7.75e-06	5.11e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—EP300—conduct disorder	7.67e-06	5.05e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EP300—conduct disorder	7.48e-06	4.93e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EP300—conduct disorder	7.44e-06	4.91e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EP300—conduct disorder	7.24e-06	4.77e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EP300—conduct disorder	7.13e-06	4.7e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—EP300—conduct disorder	7.03e-06	4.64e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—COMT—conduct disorder	6.99e-06	4.61e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MAOA—conduct disorder	6.94e-06	4.58e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EP300—conduct disorder	6.57e-06	4.33e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EP300—conduct disorder	6.46e-06	4.26e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EP300—conduct disorder	6.45e-06	4.25e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EP300—conduct disorder	6.43e-06	4.24e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EP300—conduct disorder	6.41e-06	4.23e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EP300—conduct disorder	6.35e-06	4.19e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EP300—conduct disorder	6.33e-06	4.17e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EP300—conduct disorder	5.88e-06	3.88e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—EP300—conduct disorder	5.55e-06	3.66e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—EP300—conduct disorder	4.98e-06	3.29e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—EP300—conduct disorder	4.86e-06	3.21e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—EP300—conduct disorder	4.58e-06	3.02e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—EP300—conduct disorder	4.54e-06	3e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—EP300—conduct disorder	3.88e-06	2.56e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—EP300—conduct disorder	3e-06	1.98e-05	CbGpPWpGaD
